Alimentary Pharmacology and Therapeutics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Systematic review with meta ‐analysis: anxiety and depression in children and adolescents with inflammatory bowel disease
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 9, 2018 Category: Drugs & Pharmacology Authors: L. Stapersma
,
G. van den Brink
,
E. M. Szigethy
,
J. C. Escher
,
E. M. W. J. Utens Source Type: research
Malignancy and mortality in paediatric ‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 9, 2018 Category: Drugs & Pharmacology Authors: M. E. Joosse
,
M. A. Aardoom
,
P. Kemos
,
D. Turner
,
D. C. Wilson
,
S. Koletzko
,
J. Martin ‐de‐Carpi
,
U. L. Fagerberg
,
C. Spray
,
C. Tzivinikos
,
M. Sladek
,
R. Shaoul
,
E. Roma‐Giannikou
,
J. Bronsky
,
D. E. Serban
, Source Type: research
Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten ‐free diet: beyond traditional metabolic factors
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 9, 2018 Category: Drugs & Pharmacology Authors: F. Tovoli
,
G. Negrini
,
R. Far ì
,
E. Guidetti
,
C. Faggiano
,
L. Napoli
,
L. Bolondi
,
A. Granito Source Type: research
Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 6, 2018 Category: Drugs & Pharmacology Authors: Y. Wouters
,
M. Theilla
,
P. Singer
,
S. Tribler
,
P. B. Jeppesen
,
L. Pironi
,
L. Vinter ‐Jensen
,
H. H. Rasmussen
,
F. Rahman
,
G. J. A. Wanten Source Type: research
Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 4, 2018 Category: Drugs & Pharmacology Authors: N. Plevris
,
R. Sinha
,
A. W. Hay
,
N. McDonald
,
J. N. Plevris
,
P. C. Hayes Source Type: research
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 2, 2018 Category: Drugs & Pharmacology Authors: R. El Sharkawy
,
K. Thabet
,
P. Lampertico
,
S. Petta
,
A. Mangia
,
T. Berg
,
M. Metwally
,
A. Bayoumi
,
A. Boonstra
,
W. P. Brouwer
,
A. Smedile
,
M. L. Abate
,
A. Loglio
,
M. W. Douglas
,
A. Khan
,
R. Santoro
,
J. Fisc Source Type: research
Impact of patatin ‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 29, 2018 Category: Drugs & Pharmacology Authors: M. Mandorfer
,
B. Scheiner
,
A. F. St ättermayer
,
P. Schwabl
,
R. Paternostro
,
D. Bauer
,
B. Schäfer
,
H. Zoller
,
M. Peck‐Radosavljevic
,
M. Trauner
,
T. Reiberger
,
P. Ferenci
,
A. Ferlitsch Source Type: research
Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case ‐control study in US male veterans
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 29, 2018 Category: Drugs & Pharmacology Authors: M. C. Tan
,
H. B. El ‐Serag
,
X. Yu
,
A. P. Thrift Source Type: research
A baseline tool for predicting response to peginterferon alfa ‐2a in HBeAg‐positive patients with chronic hepatitis B
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 29, 2018 Category: Drugs & Pharmacology Authors: H. L. Y. Chan
,
D. Messinger
,
G. V. Papatheodoridis
,
M. Cornberg
,
Q. Xie
,
T. Piratvisuth
,
H. Ren
,
P. T. Kennedy
,
A. Thompson
,
A. Caputo
,
G. Bakalos
,
V. Pavlovic
,
P. Lampertico Source Type: research
Interferon ‐free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 28, 2018 Category: Drugs & Pharmacology Authors: L. Gragnani
,
G. Cerretelli
,
S. Lorini
,
C. Steidl
,
A. Giovannelli
,
M. Monti
,
L. Petraccia
,
S. Sadalla
,
T. Urraro
,
P. Caini
,
A. Xheka
,
A. Simone
,
U. Arena
,
M. Matucci ‐Cerinic
,
D. Vergani
,
G. Laffi
,
A. L. Z Source Type: research
Issue Information
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 2, Page 111-113, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 25, 2018 Category: Drugs & Pharmacology Source Type: research
Editorial: real ‐life data confirm efficacy of elbasvir/grazoprevir in HCV patients with severe kidney disease
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 2, Page 226-227, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 25, 2018 Category: Drugs & Pharmacology Authors: M. G. Rumi
,
V. Occhipinti Source Type: research
Editorial: frequency of surveillance and survival in hepatocellular carcinoma —authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 2, Page 229-230, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 25, 2018 Category: Drugs & Pharmacology Authors: H. Y. Kim
,
J. ‐H. Lee Source Type: research
Editorial: real ‐life data confirm efficacy of elbasvir/grazoprevir in HCV patients with severe kidney disease—Author's reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 2, Page 227-227, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 25, 2018 Category: Drugs & Pharmacology Authors: S. L. Flamm Source Type: research
Editorial: frequency of surveillance and survival in hepatocellular carcinoma
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 2, Page 228-229, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 25, 2018 Category: Drugs & Pharmacology Authors: N. H. Senussi
,
K. V. Kowdley Source Type: research
